Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · IEX Real-Time Price · USD
1.970
-0.180 (-8.37%)
At close: Jul 19, 2024, 4:00 PM
1.980
+0.010 (0.51%)
Pre-market: Jul 22, 2024, 5:44 AM EDT
Mersana Therapeutics Market Cap
Mersana Therapeutics has a market cap or net worth of $241.05 million as of July 22, 2024. Its market cap has decreased by -39.80% in one year.
Market Cap
241.05M
Enterprise Value
90.98M
1-Year Change
-39.80%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since June 28, 2017, Mersana Therapeutics's market cap has decreased from $317.00M to $241.05M, a decrease of -23.96%. That is a compound annual growth rate of -3.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 241.10M | -13.83% |
| Dec 29, 2023 | 279.80M | -52.15% |
| Dec 30, 2022 | 584.70M | 30.72% |
| Dec 31, 2021 | 447.30M | -75.46% |
| Dec 31, 2020 | 1.82B | 564.25% |
| Dec 31, 2019 | 274.40M | 190.06% |
| Dec 31, 2018 | 94.60M | -74.69% |
| Dec 29, 2017 | 373.80M | 17.92% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Utah Medical Products | 246.67M |
| Immutep | 245.05M |
| Cibus | 244.92M |
| Cybin | 244.30M |
| Tectonic Therapeutic | 243.12M |
| Semler Scientific | 236.92M |
| Gossamer Bio | 233.01M |
| Rezolute | 232.26M |